The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.
Published: 14 Nov 2024
Citation: Uzun D, Keklik M, Eser B. Shedding light on allogeneic hematopoietic stem cell transplantation success: exploring the relationship between donor vitamin D and parathormone levels and recipient engraftment and stem cell quantity . J Curr Hematol Oncol Res. 2024;2(4):79-82.
Published: 14 Nov 2024
Citation: Balık B, Mutlu YG, Sevindik ÖG. Myeloid differentiation primary response 88 expression in central nervous system lymphomas. J Curr Hematol Oncol Res. 2024;2(4):83-86.
Published: 14 Nov 2024
Citation: Yılmaz S, Günay A, Cırık S, Baştürk A, Başdemirci M, Balasar Ö. Diagnostic white blood cells can be a predictor for mutation existence in myelodisplastic syndromes: the role of next generation sequencing. J Curr Hematol Oncol Res. 2024;2(4):87-92.
Published: 14 Nov 2024
Citation: Tan T, Doğan ÖD, Civriz Bozdağ S. Can bispecific antibody therapies for multiple myeloma be a risk factor for the development of secondary haemotopoietic malignancy? A case report. J Curr Hematol Oncol Res. 2024; 2(4): 93-94.
Published: 14 Nov 2024
Citation: Çiftciler R, Çiftciler AE, Selim C, Çelik M. Kikuchi-Fujimoto disease: a rare cause of fever and lymphadenopathy in a 19-year-old male . J Curr Hematol Oncol Res. 2024;2(4): 95-97.
Published: 14 Nov 2024
Citation: Karatlı S, Kavak EE. A rare case of olfactory neuroblastoma. J Curr Hematol Oncol Res. 2024;2(4):98-99.
Published: 14 Nov 2024
Citation: Güven İE. The relationship between hepatocellular carcinoma and resolvin D1. J Curr Hematol Oncol Res. 2024;2(4):100.
Published: 30 Aug 2023
Citation: Barış Iİ, Büyükbayram H. ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status. J Curr Hematol Oncol Res. 2023;1(3):54-58.
Published: 30 Aug 2023
Citation: Fidan K. Chronic lymphocytic leukemia. J Curr Hematol Oncol Res. 2023;1(3):59-67.
Published: 26 Feb 2023
Citation: Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4